Other studies have shown expression of epithelial differentiation markers such as androgen receptor and prostate specific membrane antigen [35, 36], hypoxia (carbonic anhydrase IX, hypoxia inducible factor 1α) [37], and PTEN pathway activation [38] are increased in higher grade cancers. The gene discussed is FOLH1; the disease is cancer.